Page last updated: 2024-08-25

oxazolidin-2-one and Alloxan Diabetes

oxazolidin-2-one has been researched along with Alloxan Diabetes in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chhibber, S; Kaur, T1
Morinet, F1
Bae, SK; Kim, WB; Kwon, JW; Lee, DC; Lee, MG; Lee, SJ; Yang, SH1

Other Studies

3 other study(ies) available for oxazolidin-2-one and Alloxan Diabetes

ArticleYear
Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections.
    PloS one, 2013, Volume: 8, Issue:2

    Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriophages; Diabetes Mellitus, Experimental; Diabetic Foot; Linezolid; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Oxazolidinones; Staphylococcal Skin Infections; Treatment Outcome

2013
[Bacteriophage therapy and diabetic foot ulcer].
    Pathologie-biologie, 2013, Volume: 61, Issue:2

    Topics: Acetamides; Animals; Anti-Infective Agents; Bacteriophages; Combined Modality Therapy; Diabetes Mellitus, Experimental; Diabetic Foot; Humans; Linezolid; Mice; Mice, Inbred BALB C; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Superinfection

2013
Pharmacokinetic changes of DA-7867, a new oxazolidinone, after intravenous and oral administration to rats with short-term and long-term diabetes mellitus induced by streptozotocin.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2005, Volume: 25, Issue:2-3

    Topics: Administration, Oral; Animals; Area Under Curve; Diabetes Mellitus, Experimental; Injections, Intravenous; Male; Metabolic Clearance Rate; Oxazolidinones; Rats; Rats, Sprague-Dawley; Streptozocin; Time Factors

2005